EPO Patents = 3

Trademarks = 5

Forward Citations = 0

Loading Chart...

6 inventors (with patents filed for the assignee):

Stefan Robbert Braam (6 out of 6 patents)

Ana Catarina Martins Grandela (2 out of 2 patents)

Leon Tertoolen (1 out of 1 patent)

4. Fleur Stevenhagen (1 out of 1 patent)

5. Christine Lindsay Mummery (1 out of 8 patents)

6. Karin Langenberg (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12043846 - Cardiomyocytes derived from pluripotent mammalian stem cells (2024-07-23),

2. 11773375 - In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytes (2023-10-03),

3. 11136551 - In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population (2021-10-05),

4. 10844354 - Cardiomyocyte maturation (2020-11-24),

5. 10696947 - Culture medium composition for maturating cardiomyocytes derived from pluripotent mammalian stem cells (2020-06-30),

6. 10613078 - Assays for measuring cardiotoxicity (2020-04-07),

Ncardia is a leading provider of human iPSC-derived cells, cardiac and neural assays, and comprehensive drug discovery services for the pharmaceutical industry and academic research. With state-of-the-art technology and a team of experts, Ncardia accelerates drug discovery, development, and safety testing for a wide range of therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

6 Patents

#21 in Leiden

#947 in Netherlands

Leiden, Netherlands

Ncardia B.v.